Wave Life Sciences Ltd. (WVE) — Stock Score Summary

Wave Life Sciences Ltd. (WVE) has a MoatMap StockRank of 7/100 based on Quality (32/100), Value (38/100), and Momentum (15/100) factor scores. The current signal is STRONG SELL. A clinical-stage genetic medicine company with highly volatile binary outcomes, making it unsuitable for a concentrated quality-first portfolio.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company designing stereopure oligonucleotides to treat genetically defined diseases. The company's competitive moat is its proprietary PRISM platform, which enables the precise design of RNA-targeting therapeutics with optimized pharmacological properties. It operates as an innovative niche player in the precision genetic medicine sector.

Key Financial Metrics

Price$5.78
Market Cap$1.2B
P/E (Forward)-5.50
Price/Book2.20
Return on Equity-53.1%
Return on Invested Capital-39.6%
Debt/Equity3.07
Gross Margin-164.1%
Operating Margin-81.8%
Revenue Growth316.9%
Free Cash Flow$-126M

Wave Life Sciences Ltd. operates in the Biotechnology industry, part of the Healthcare sector (Singapore).

Frequently Asked Questions

What is Wave Life Sciences Ltd.’s (WVE) StockRank?
MoatMap’s StockRank for Wave Life Sciences Ltd. (WVE) is 7/100, with a Strong Sell signal. It is a composite of Quality (32), Value (38), and Momentum (15) factor ranks across MoatMap’s 19,000+ stock universe.
Does Wave Life Sciences Ltd. have an economic moat?
Wave Life Sciences Ltd. (WVE) has a Quality factor score of 32/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Wave Life Sciences Ltd. a buy, hold, or sell?
MoatMap’s current signal for Wave Life Sciences Ltd. (WVE) is Strong Sell, based on a StockRank of 7/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Wave Life Sciences Ltd. in?
Wave Life Sciences Ltd. (WVE) operates in the Healthcare sector, specifically the Biotechnology industry (Singapore).
Browse all ranked stocksWVE deep dive reportAI ChampionsHow we score stocksSense-check another stock